Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Viable Monetary Tips to Advance Your Monetary Circumstance - 2College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- 3I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
- 4Figure out How to Protect Your Gold Venture from Unpredictability
- 5Mom warns of Christmas gift hazard as daughter recovers in hospital
- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- Famous Network programs in Europe and America
- Medical team successfully delivers baby and removes massive tumor
- Fundamental Venture The board Apparatuses for Remote Groups
- Extreme Manual for Purchasing Your Next Truck
- Some Americans say they'll go without health insurance as ACA rates spike
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- Must-Have Wellness Gear: What to Purchase for Successful Exercises
- The biggest black hole breakthroughs of 2025
